ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Approves Twyneo (tretinoin and benzoyl peroxide) for the Treatment of Acne Vulgaris
July 28, 2021Sol-Gel Technologies, Ltd. today announced that FDA has approved its first proprietary drug product, Twyneo cream, 0.1%/3%, indicated for the treatment of acne vulgaris in adults and pediatric patients nine years of age and older. -
Sol-Gel Technologies Announces FDA Approval of TWYNEO
July 28, 2021Sol-GSol-Gel Technologies approved its first proprietary drug product, TWYNEO (tretinoin/benzoyl peroxide) cream, 0.1%/3%, indicated for the treatment of acne vulgaris in adults and pediatric patients nine years.
Pharma Sources Insight January 2025
